Feature
Biomarker-Based Trial Search
Biomarkers can dramatically change which colorectal cancer trials are relevant and how quickly patients can rule options in or out.
What biomarker-aware search adds
Patients with MSS, KRAS, BRAF V600E, HER2, or other trial-relevant findings often need a search flow that recognizes those differences immediately.
Second Look Cancer is designed to make biomarker context visible early so patients can spend less time sorting through obviously mismatched studies.
Why context still matters
A biomarker alone does not determine trial fit. Prior lines of therapy, resectability, geography, performance status, and surgical history often matter just as much.
That is why the product aims to keep biomarker search connected to the rest of the patient profile rather than treating it as a single-filter problem.